Global /South Korea /Healthcare /Drug Manufacturers - General /017180
chevron_leftBack
MYUNGMOON Pharm co.,Ltd logo

MYUNGMOON Pharm co.,Ltd

017180
KRX: 017180 Delayed
1,788KRW 0%
1.17 USD
As of 13 June 2026, MYUNGMOON Pharm co.,Ltd has a market cap of $39.3M USD, ranking #32305 globally and #1913 in South Korea. It ranks #2922 in the Healthcare sector, and #1011 in the Drug Manufacturers - General industry.
Global Rank
32305
Country Rank
1913
Sector Rank
2922
Industry Rank
1011
Key Stats
Market Cap
$39.3MUSD
59.77B KRW
Enterprise Value
$103.51MUSD
157.97B KRW
Revenue (TTM)
$128.38MUSD
195.25B KRW
EBITDA (TTM)
$7.07MUSD
10.8B KRW
Net Income (TTM)
$1.25MUSD
1.9B KRW
EBITDA Margin
5.5%
Profit Margin
1%
PE Ratio
31.4
PS Ratio
0.3
PB Ratio
0.6
EV/EBITDA
14.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Cheol-han Bae open_in_new
Employees
291
Founded
1983
Website
mmpharm.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -0.5% -5.9% -2% 11% 9.1%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
017180
명문제약(주)
ISIN: KR7017180001
Shares Out.:
33.428M1 Shares Float: 25.0M2
TV:
SA:
YF:
GF:
BA:
MS:
1,788 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, antidiarrheal agents, digestive system products, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.15B
13.91T KRW
23K%
-
$6.77B
10.3T KRW
17K%
1958.1
$5.24B
7.97T KRW
13K%
29.9
298380
$4.96B
7.55T KRW
13K%
-
000100
$4.55B
6.92T KRW
11K%
35.9
$4.44B
6.76T KRW
11K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
2M%
38.1
JNJ
$547.28B
1M%
26.4
ABBV
$360.63B
918K%
97.4
$321.52B
256.25B CHF
818K%
19.9
AZN
$288.84B
215.59B GBP
735K%
27.6
NOVN
$274.65B
218.9B CHF
699K%
20.5
chevron_leftBack